# Seroconversion in COVID-19 Recovered Population

> **NCT04558385** · — · COMPLETED · sponsor: **Lahore General Hospital** · enrollment: 275 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** IgG SARS CoV2

## Key facts

- **NCT ID:** NCT04558385
- **Lead sponsor:** Lahore General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04558385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04558385, "Seroconversion in COVID-19 Recovered Population". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04558385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*